PARAGARD T380A Rx
Generic Name and Formulations:
Copper-bearing intrauterine contraceptive device.
The Cooper Companies
Indications for PARAGARD T380A:
See literature. ≥16yrs: Insert into uterine cavity. Check placement shortly after first menses. Replace at least every 10 years.
<16yrs: not recommended.
Uterine abnormality. Uterine or cervical malignancy. Pelvic inflammatory disease or risk thereof. Postpartum or postabortal endometritis in the past 3 months. Genital actinomycosis. Abnormal genital bleeding. Cervicitis. Wilson's disease. Retained IUD. Pregnancy or suspicion of pregnancy.
Vaginal bleeding. Ectopic pregnancy. Immunocompromised. Immunosuppressive therapy. Avoid medical diathermy. Assure suitable uterine anatomy before insertion. Remove the device if evidence of partial expulsion, perforation, or breakage.
Bleeding, cramps, anemia, dyspareunia, pelvic infection, infertility, ectopic pregnancy, uterine or cervical perforation, embedment or fragmentation of device, septicemia (during pregnancy), spontaneous abortion, vasovagal reactions (during insertion or removal).
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Comorbid Narcolepsy and Schizophrenia in Adolescents
- Ketamine in Electroconvulsive Therapy Accelerates Antidepressive Effects
- Quetiapine Exposure Does Not Appear to Increase Risk for Infant Malformations
- Selective Serotonin Reuptake Inhibitors May Increase Risk for Suboptimal Fetal Growth
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Prenatal Insecticide Exposure in Mother May Be Linked to Risk for Autism in Children